AI Portfolio Summary
In 2025 Q4, KOTLER KEVIN maintained a portfolio of 38 distinct positions. The most significant new addition to the portfolio was SPDR S&P 500 ETF TR, which now represents 55.83% of the total fund value.
Total Positions
38
Quarter
2025 Q4
Top Holding
SPY (55.8%)
Top 10 Concentration
89.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 38
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SPY
PUT
SPDR S&P 500 ET...
|
PUT Option | 55.83% | — |
#1
Prev: #—
|
10.0 | 350,000 | no change |
NEW
|
350,000 | $238,672,000 |
$680.06
+0.9%
|
2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
QQQ
PUT
INVESCO QQQ TR
|
PUT Option | 7.18% | — |
#2
Prev: #—
|
4.9 | 50,000 | no change |
NEW
|
50,000 | $30,715,500 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ANGO
ANGIODYNAMICS I...
|
Healthcare | 5.15% | — |
#3
Prev: #—
|
4.1 | 1,713,789 | no change |
NEW
|
1,713,789 | $21,997,218 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AUPH
AURINIA PHARMAC...
|
Healthcare | 4.57% | — |
#4
Prev: #—
|
3.8 | 1,224,846 | no change |
NEW
|
1,224,846 | $19,536,294 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AVDL
CALL
AVADEL PHARMACE...
|
CALL Option | 4.43% | — |
#5
Prev: #—
|
3.8 | 879,400 | no change |
NEW
|
879,400 | $18,951,070 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AVDL
AVADEL PHARMACE...
|
Healthcare | 3.74% | — |
#6
Prev: #—
|
3.5 | 741,343 | no change |
NEW
|
741,343 | $15,975,942 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OMER
OMEROS CORP
|
Healthcare | 3.64% | — |
#7
Prev: #—
|
3.5 | 905,635 | no change |
NEW
|
905,635 | $15,554,281 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NPCE
NEUROPACE INC
|
Healthcare | 2.28% | — |
#8
Prev: #—
|
2.9 | 631,468 | no change |
NEW
|
631,468 | $9,749,866 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MDWD
MEDIWOUND LTD
|
Healthcare | 1.46% | — |
#9
Prev: #—
|
2.6 | 337,236 | no change |
NEW
|
337,236 | $6,225,377 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AXGN
AXOGEN INC
|
Healthcare | 1.29% | — |
#10
Prev: #—
|
2.5 | 168,000 | no change |
NEW
|
168,000 | $5,498,640 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IART
INTEGRA LIFESCI...
|
Healthcare | 1.24% | — |
#11
Prev: #—
|
2.5 | 427,445 | no change |
NEW
|
427,445 | $5,308,867 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACRS
ACLARIS THERAPE...
|
Healthcare | 1.20% | — |
#12
Prev: #—
|
2.5 | 1,705,929 | no change |
NEW
|
1,705,929 | $5,134,846 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EVTL
VERTICAL AEROSP...
|
Industrials | 1.17% | — |
#13
Prev: #—
|
2.5 | 939,705 | no change |
NEW
|
939,705 | $5,008,628 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OSUR
ORASURE TECHNOL...
|
Healthcare | 1.02% | — |
#14
Prev: #—
|
2.4 | 1,801,446 | no change |
NEW
|
1,801,446 | $4,359,499 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OMER
CALL
OMEROS CORP
|
CALL Option | 0.89% | — |
#15
Prev: #—
|
2.4 | 218,700 | no change |
NEW
|
218,700 | $3,794,445 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GLPG
GALAPAGOS NV
|
Healthcare | 0.69% | — |
#16
Prev: #—
|
2.3 | 90,000 | no change |
NEW
|
90,000 | $2,943,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 0.50% | — |
#17
Prev: #—
|
2.2 | 2,000 | no change |
NEW
|
2,000 | $2,149,360 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CERS
CERUS CORP
|
Healthcare | 0.49% | — |
#18
Prev: #—
|
2.2 | 1,011,614 | no change |
NEW
|
1,011,614 | $2,083,925 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NKE
NIKE INC
|
Consumer Cyclical | 0.48% | — |
#19
Prev: #—
|
2.2 | 32,000 | no change |
NEW
|
32,000 | $2,038,720 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TECX
TECTONIC THERAP...
|
Healthcare | 0.39% | — |
#20
Prev: #—
|
2.2 | 80,000 | no change |
NEW
|
80,000 | $1,668,800 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CLYM
CLIMB BIO INC
|
Healthcare | 0.37% | — |
#21
Prev: #—
|
2.1 | 400,000 | no change |
NEW
|
400,000 | $1,600,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TMCI
TREACE MED CONC...
|
Healthcare | 0.27% | — |
#22
Prev: #—
|
2.1 | 474,365 | no change |
NEW
|
474,365 | $1,162,194 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TLSI
TRISALUS LIFE S...
|
Healthcare | 0.24% | — |
#23
Prev: #—
|
2.1 | 145,200 | no change |
NEW
|
145,200 | $1,013,496 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DXCM
DEXCOM INC
|
Healthcare | 0.23% | — |
#24
Prev: #—
|
2.1 | 15,000 | no change |
NEW
|
15,000 | $995,550 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VNDA
VANDA PHARMACEU...
|
Healthcare | 0.21% | — |
#25
Prev: #—
|
2.1 | 100,000 | no change |
NEW
|
100,000 | $882,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 38 holdings